Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

作者: Nancy L. Geller , Cora N. Sternberg , Darryl Penenberg , Howard Scher , Alan Yagoda

DOI: 10.1002/1097-0142(19910315)67:6<1525::AID-CNCR2820670611>3.0.CO;2-8

关键词:

摘要: Between February 1983 and February 1986, 132 patients with advanced urothelial tract tumors were treated with methotrexate, vinblastine, Adriamycin (doxorubicin), and cisplatin (M‐…

参考文章(15)
Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Harry W. Herr, Michael J. Morse, Pramod C. Sogani, E. Darracott Vaughan, Neil Bander, Lora R. Weiselberg, Nancy Geller, Phyllis S. Hollander, Roberta Lipperman, William R. Fair, Willet F. Whitmore, M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. The Journal of Urology. ,vol. 139, pp. 461- 469 ,(1988) , 10.1016/S0022-5347(17)42494-3
Cora N. Sternberg, H. I. Scher, Management of Invasive Bladder Neoplasms Springer London. pp. 95- 118 ,(1989) , 10.1007/978-1-4471-1655-4_6
Patti S. Reinhardt, SAS supplemental library user's guide SAS Institute. ,(1980)
Stephenie P. Joyner, SUGI supplemental library user's guide SAS Institute. ,(1983)
Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Robin C. Watson, Nancy Geller, Harry W. Herr, Michael J. Morse, Pramod C. Sogani, E. Darracott Vaughan, Neil Bander, Lora Weiselberg, Kim Rosado, Tracy Smart, Shiow-Yun Lin, Darryl Penenberg, William R. Fair, Willet F. Whitmore, Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cancer. ,vol. 64, pp. 2448- 2458 ,(1989) , 10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Wayne Nelson, Theory and applications of hazard plotting for censored failure data Technometrics. ,vol. 42, pp. 12- 25 ,(2000) , 10.2307/1271428
D. RAGHAVAN, R. GRUNDY, T. M. GREENAWAY, B. S. PEARSON, J. ROGERS, P. DUVAL, M. MEAGHER, HEDY MAMEGHAN, Pre-emptive (neo-adjuvant) chemotherapy prior to radical radiotherapy for fit septuagenarians with bladder cancer: age itself is not a contra-indication. BJUI. ,vol. 62, pp. 154- 159 ,(1988) , 10.1111/J.1464-410X.1988.TB04297.X
Mantel N, Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer chemotherapy reports. ,vol. 50, pp. 163- 170 ,(1966)